Q2 Earnings Estimate for Acadia Healthcare Issued By KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities researchers at KeyCorp reduced their Q2 2025 EPS estimates for Acadia Healthcare in a research report issued on Monday, January 6th. KeyCorp analyst M. Gillmor now forecasts that the company will earn $0.85 per share for the quarter, down from their previous forecast of $1.00. KeyCorp has a “Overweight” rating and a $70.00 price target on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.92 EPS.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same quarter last year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis.

ACHC has been the topic of several other research reports. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday. Barclays dropped their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, TD Cowen decreased their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Stock Down 0.0 %

Shares of ACHC stock opened at $45.12 on Wednesday. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a market capitalization of $4.19 billion, a price-to-earnings ratio of 14.79, a PEG ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock’s 50 day simple moving average is $40.48 and its 200 day simple moving average is $58.19.

Institutional Trading of Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. GAMMA Investing LLC increased its position in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare during the 2nd quarter worth about $59,000. Covestor Ltd lifted its holdings in shares of Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after purchasing an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter worth about $86,000. Finally, Assetmark Inc. grew its holdings in shares of Acadia Healthcare by 66.1% during the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock worth $94,000 after buying an additional 591 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.